Udine, Italy

Claudio Schneider

This inventor holds 1 USPTO granted patent. Top assignees: Amgen Inc., Other. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claudio Schneider. Retrieved from https://idiyas.com/inventor/claudio-schneider-ee5umwtz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:

goldMedal1 out of 2,074 
 
Amgen Inc.
 patents
silverMedal1 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Claudio Schneider

Introduction

Claudio Schneider is a notable inventor based in Udine, Italy. He has made significant contributions to the field of biotechnology, particularly in the area of receptor signaling. His work has implications for understanding various biological processes and potential therapeutic applications.

Latest Patents

One of Claudio Schneider's key patents is titled "DNA encoding a stimulating factor for the axl receptor." This patent describes a protein known as gas6, which acts as a stimulator and presumed ligand for the axl receptor. The protein has been identified and sequenced, showing homology to human protein S and functioning as a growth factor for tissues that express axl. This innovation highlights Schneider's expertise in molecular biology and its applications in medical science.

Career Highlights

Throughout his career, Claudio Schneider has worked with prominent companies, including Amgen Inc. His experience in the biotechnology sector has allowed him to contribute to various research projects and advancements in the field. His work has been instrumental in furthering the understanding of receptor biology and its implications for health and disease.

Collaborations

Claudio Schneider has collaborated with esteemed colleagues, including Guidalberto Manfioletti and Claudio Brancolini. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the scientific community.

Conclusion

Claudio Schneider's contributions to biotechnology, particularly through his patent on the axl receptor, demonstrate his commitment to advancing scientific knowledge. His collaborations and career achievements reflect his significant impact on the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…